Reckitt Benckiser Group PLC (OTCMKTS:RBGLY – Get Free Report) was the recipient of a large increase in short interest during the month of April. As of April 30th, there was short interest totaling 842,591 shares, an increase of 703.2% from the April 15th total of 104,904 shares. Based on an average daily trading volume, of 2,374,575 shares, the short-interest ratio is currently 0.4 days. Approximately 0.0% of the company’s shares are short sold.
Reckitt Benckiser Group Price Performance
OTCMKTS RBGLY traded down $0.16 on Wednesday, reaching $12.37. The company had a trading volume of 529,795 shares, compared to its average volume of 647,291. The company has a quick ratio of 0.63, a current ratio of 0.85 and a debt-to-equity ratio of 0.98. Reckitt Benckiser Group has a 1 year low of $12.29 and a 1 year high of $17.80. The firm has a 50-day moving average of $13.86 and a 200-day moving average of $15.42.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on RBGLY shares. Royal Bank Of Canada lowered shares of Reckitt Benckiser Group from an “outperform” rating to a “sector perform” rating in a report on Wednesday, January 14th. Zacks Research lowered shares of Reckitt Benckiser Group from a “hold” rating to a “strong sell” rating in a research report on Tuesday, April 7th. Morgan Stanley upgraded shares of Reckitt Benckiser Group from an “equal weight” rating to an “overweight” rating in a report on Monday, March 16th. Kepler Capital Markets raised shares of Reckitt Benckiser Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, April 17th. Finally, Citigroup started coverage on Reckitt Benckiser Group in a research report on Wednesday, January 14th. They issued a “buy” rating on the stock. Three equities research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy”.
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.
The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.
Featured Articles
- Five stocks we like better than Reckitt Benckiser Group
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
